Status:
WITHDRAWN
Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Conditions:
Migraine
Headache
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether topiramate effective in treating dizziness symptoms that are associated with migraine headaches.
Detailed Description
Migraine is a common disorder, often associated with dizziness symptoms. In many cases, dizziness is one of the only manifestations of migraine headaches. Various classes of drugs have been advocated ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of migraine-associated dizziness.
Exclusion
- Previous or current use of topiramate prior to study enrollment.
- Need for continued use of the following medications for any medical reason during the study: ergots, anti-epileptics, beta-blockers, calcium channel blockers, monoamine oxidase inhibitors, high-dose magnesium, high-dose riboflavin, corticosteroids, local anesthetics, botulinum toxin, or herbal preparations.
- History of nephrolithiasis.
- Women whom are pregnant or breastfeeding.
- Patients with known sensitivity to topiramate.
- Patients with a history of glaucoma.
- Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00732108
Start Date
November 1 2008
Last Update
March 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143